Fierce Biotech

Subscribe to Fierce Biotech feed
Updated: 4 hours 40 min ago

Report: Europe leads in number of clinical trials for cystic fibrosis, North America for AML

Tue, 04/16/2024 - 11:32
Report: Europe leads in number of clinical trials for cystic fibrosis, North America for AML hfloersh Tue, 04/16/2024 - 14:32

J&J CEO says M&A strategy 'will continue' after medtech megadeals

Tue, 04/16/2024 - 10:48
J&J CEO says M&A strategy 'will continue' after medtech megadeals chale Tue, 04/16/2024 - 13:48

Takeda inks sweet $1.2B+ deal with Kumquat for immuno-oncology program

Tue, 04/16/2024 - 08:20
Takeda inks sweet $1.2B+ deal with Kumquat for immuno-oncology program gmasson Tue, 04/16/2024 - 11:20

PacBio plots budget cuts after DNA sequencing revenue shortfalls

Tue, 04/16/2024 - 08:04
PacBio plots budget cuts after DNA sequencing revenue shortfalls chale Tue, 04/16/2024 - 11:04

Cullinan rebrands, halts lymphoma trial to reflect autoimmune refocus

Tue, 04/16/2024 - 06:27
Cullinan rebrands, halts lymphoma trial to reflect autoimmune refocus jwaldron Tue, 04/16/2024 - 09:27

Startup SelSym hopes to control bleeding with squishy synthetic platelets

Mon, 04/15/2024 - 12:31
Startup SelSym hopes to control bleeding with squishy synthetic platelets hfloersh Mon, 04/15/2024 - 15:31

FDA delivers de novo clearances to 2 novel antibacterial implant coatings

Mon, 04/15/2024 - 10:21
FDA delivers de novo clearances to 2 novel antibacterial implant coatings chale Mon, 04/15/2024 - 13:21

Butterfly Network expands maternal ultrasound efforts across Africa

Mon, 04/15/2024 - 07:30
Butterfly Network expands maternal ultrasound efforts across Africa chale Mon, 04/15/2024 - 10:30

Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond

Mon, 04/15/2024 - 07:01
Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond mbayer Mon, 04/15/2024 - 10:01

Pulmocide exits OPERA with phase 2 evidence of antifungal safety and efficacy

Mon, 04/15/2024 - 06:42
Pulmocide exits OPERA with phase 2 evidence of antifungal safety and efficacy ntaylor Mon, 04/15/2024 - 09:42

Neumora's schizophrenia drug faces FDA hold over convulsions in rabbits

Mon, 04/15/2024 - 05:00
Neumora's schizophrenia drug faces FDA hold over convulsions in rabbits jwaldron Mon, 04/15/2024 - 08:00

MaaT, eyeing 2026 launch for microbiome therapy, posts 18-month data in aGvHD

Mon, 04/15/2024 - 02:03
MaaT, eyeing 2026 launch for microbiome therapy, posts 18-month data in aGvHD jwaldron Mon, 04/15/2024 - 05:03

Roche picks up Prenosis' newly cleared sepsis AI tool for distribution

Fri, 04/12/2024 - 10:25
Roche picks up Prenosis' newly cleared sepsis AI tool for distribution chale Fri, 04/12/2024 - 13:25

Genentech axes Adaptimmune cell therapy deal as it presses ahead with staff cuts

Fri, 04/12/2024 - 08:07
Genentech axes Adaptimmune cell therapy deal as it presses ahead with staff cuts gmasson Fri, 04/12/2024 - 11:07

Portage Biotech hints at potential closure as it halts programs, hunts for strategic options

Fri, 04/12/2024 - 07:33
Portage Biotech hints at potential closure as it halts programs, hunts for strategic options mbayer Fri, 04/12/2024 - 10:33

Illumina gets go-ahead from European Commission to part ways with Grail

Fri, 04/12/2024 - 07:13
Illumina gets go-ahead from European Commission to part ways with Grail chale Fri, 04/12/2024 - 10:13

Enlivex defends sepsis data that sank stock, shifting focus from mortality to subgroup analysis

Fri, 04/12/2024 - 06:31
Enlivex defends sepsis data that sank stock, shifting focus from mortality to subgroup analysis ntaylor Fri, 04/12/2024 - 09:31

Novartis may have bought MorphoSys, but it really only had eyes for BET inhibitor pelabresib: filing

Fri, 04/12/2024 - 03:26
Novartis may have bought MorphoSys, but it really only had eyes for BET inhibitor pelabresib: filing jwaldron Fri, 04/12/2024 - 06:26

Chutes & Ladders—Top BIO lobbyist quickly exits after BIOSECURE reversal

Thu, 04/11/2024 - 12:02
Chutes & Ladders—Top BIO lobbyist quickly exits after BIOSECURE reversal gmasson Thu, 04/11/2024 - 15:02

Peak Rock Capital takes a bite out of Steris with $787M dental business deal

Thu, 04/11/2024 - 09:53
Peak Rock Capital takes a bite out of Steris with $787M dental business deal chale Thu, 04/11/2024 - 12:53